Get the Stockscreener App
2.32
3.11%
0.07
After Hours:
2.30
-0.02
-0.86%
Mural Oncology Plc stock is traded at $2.32, with a volume of 197.65K.
It is up +3.11% in the last 24 hours and down -7.20% over the past month.
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
See More
Previous Close:
$2.25
Open:
$2.29
24h Volume:
197.65K
Relative Volume:
1.40
Market Cap:
$40.06M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.25%
1M Performance:
-7.20%
6M Performance:
-38.13%
1Y Performance:
-33.33%
1-Day Range:
$2.28
$2.40
1-Week Range:
$2.18
$2.45
52-Week Range:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Name
Mural Oncology Plc
Sector
Industry
Phone
353 1 905 8020
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare MURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.32 | 38.85M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-25-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-04-24 | Initiated | Morgan Stanley | Overweight |
Mural Oncology Plc Stock (MURA) Latest News
What analysts say about Mural Oncology plc stockNavigate the market with precision tools - jammulinksnews.com
What institutional investors are buying Mural Oncology plc stockGet real-time alerts on top stocks - jammulinksnews.com
Is it the right time to buy Mural Oncology plc stockUnprecedented market success - jammulinksnews.com
What are analysts’ price targets for Mural Oncology plc in the next 12 monthsInvest smarter with data-backed trading alerts - jammulinksnews.com
What makes Mural Oncology plc stock price move sharplyHigh-profit capital plays - jammulinksnews.com
Mural Oncology plc Stock Analysis and ForecastDiscover breakthrough trading strategies - jammulinksnews.com
How volatile is Mural Oncology plc stock compared to the marketEarnings Report Alerts To Watch Now - jammulinksnews.com
Form 8.3Mural Oncology plc - Business Wire
How strong is Mural Oncology plc company’s balance sheetExpert Picks Ideas For Smart Trading - jammulinksnews.com
Mural Oncology plc Forms Bullish Flag — Upside AheadDaily Stock Market Swing Alerts Highlight Key Movers - beatles.ru
Is Mural Oncology plc the Top Chart Pick This WeekAlpha Focused Technical Trade Signals Gain Attention - metal.it
Can Mural Oncology plc Regain Lost Ground This QuarterTechnical Stock Breakout Predictions Signal Entry Points - metal.it
Support Zone Holds Steady for Mural Oncology plc After DipShort Term Trading Opportunity Watch Sees Shift - metal.it
Disclosure of Opening Position in Mural Oncology plc by The Vanguard Group, Inc. - AInvest
Mural Oncology plc Price Targets Raised After ReboundTrade Timing Strategy With Technical Data Explained - metal.it
Mural Oncology plc Attempts Reversal From Key SupportCommunity Verified Stock Suggestions Drive Volume - metal.it
Watch for Trend Continuation in Mural Oncology plc Next WeekStock Selection With High Accuracy Based on Models - metal.it
Real Time Chart Alerts Flash Bullish on Mural Oncology plcCapital Preserving Trade Plan Templates Shared - metal.it
Should I hold or sell Mural Oncology plc stock in 2025Unlock your portfolio’s full growth potential - jammulinksnews.com
Mural Oncology plc Pullback Analyzed — Is It Time to ExitOversold Bounce Stock Play Ideas Gain Attention - metal.it
How Resilient Is Mural Oncology plc Stock During Economic DownturnsTop Performing Low Risk Stocks - metal.it
Is Mural Oncology plc a good long term investmentUnmatched market gains - PrintWeekIndia
Will Mural Oncology plc stock benefit from interest rate changesBreakthrough profit margins - jammulinksnews.com
Is Mural Oncology plc stock a growth or value playBreakneck growth rates - jammulinksnews.com
What drives Mural Oncology plc stock priceHigh-yield investments - jammulinksnews.com
Why Mural Oncology plc stock attracts strong analyst attentionReturn Maximized Portfolio Strategy - Newser
Can Mural Oncology (NASDAQ:MURA) Afford To Invest In Growth? - Yahoo Finance
Mural Oncology Plc Stock (MURA) Financials Data
There is no financial data for Mural Oncology Plc (MURA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Mural Oncology Plc Stock (MURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):